ACI
WST icon

AMP Capital Investors’s West Pharmaceutical WST Stock Holding History

AMP Capital Investors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-31,050
Closed -$13.2M – 997
2021
Q3 		$13.2M Buy
31,050
+167
+0.5% +$70.4K 0.07% 294
2021
Q2 		$11.1M Sell
30,883
-11,944
-28% -$3.95M 0.05% 384
2021
Q1 		$12.1M Sell
42,827
-802
-2% -$230K 0.06% 348
2020
Q4 		$12.2M Buy
43,629
+5,865
+16% +$1.65M 0.07% 322
2020
Q3 		$10.3M Buy
37,764
+7,897
+26% +$2.09M 0.06% 322
2020
Q2 		$6.57M Buy
29,867
+51
+0.2% +$10K 0.04% 424
2020
Q1 		$4.53M Buy
29,816
+15,626
+110% +$2.41M 0.03% 467
2019
Q4 		$2.14M Buy
14,190
+9,690
+215% +$1.41M 0.01% 751
2019
Q3 		$634K Buy
4,500
+2,634
+141% +$363K ﹤0.01% 941
2019
Q2 		$231K Sell
1,866
-240
-11% -$28.3K ﹤0.01% 1125
2019
Q1 		$227K Sell
2,106
-160
-7% -$16.6K ﹤0.01% 1103
2018
Q4 		$218K Sell
2,266
-144
-6% -$15.6K ﹤0.01% 1088
2018
Q3 		$296K Sell
2,410
-1,250
-34% -$140K ﹤0.01% 1083
2018
Q2 		$363K Sell
3,660
-300
-8% -$27.6K ﹤0.01% 1040
2018
Q1 		$343K Buy
3,960
+670
+20% +$62.7K ﹤0.01% 1052
2017
Q4 		$325K Sell
3,290
-80
-2% -$7.84K ﹤0.01% 1084
2017
Q3 		$324K Sell
3,370
-6,213
-65% -$562K ﹤0.01% 1044
2017
Q2 		$905K Buy
9,583
+5,333
+125% +$491K 0.01% 877
2017
Q1 		$348K Buy
4,250
+640
+18% +$53.5K ﹤0.01% 1035
2016
Q4 		$308K Sell
3,610
-370
-9% -$29.1K ﹤0.01% 1063
2016
Q3 		$293K Buy
3,980
+1,080
+37% +$85.7K ﹤0.01% 1090
2016
Q2 		$215K Buy
+2,900
New +$211K ﹤0.01% 1102
2013
Q3 		– Sell
-15,818
Closed -$556K – 1305
2013
Q2 		$556K Buy
+15,818
New +$521K ﹤0.01% 1041

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AMP Capital Investors's WST Position: Q4 2021 in Review

AMP Capital Investors sold out of West Pharmaceutical (WST) in Q4 2021, closing a stake of 31,050 shares — an estimated $13.2M sold.

AMP Capital Investors first reported a position in WST in Q2 2013 and held it in 23 quarters. The position peaked at $13.2M in Q3 2021. 731 funds tracked by Wall St. Rank hold WST as of Q4 2021.

  • AMP Capital Investors reported no remaining West Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 31,050 West Pharmaceutical shares in Q4 2021, an estimated $13.2M.
  • AMP Capital Investors first reported a position in West Pharmaceutical in Q2 2013 and held it in 23 quarters.
  • AMP Capital Investors's West Pharmaceutical position peaked at $13.2M in Q3 2021.
  • 731 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.